The focus on developing a vaccine for the treatment of COVID-19 is, in fact, disrupting many upcoming and/or ongoing clinical trials on other diseases around the globe.
With the redirection of resources and temporary halting of in-person visits, studies in other therapeutic areas have been unavoidably constrained.
However, the COVID-19 response has also introduced innovations that have advanced our overall conduct of clinical research.The following article aims to introduce the new Global trends in Clinical Research due to the Pandemic.
Covid-19 had a huge impact on the way clinical trials are managed and conducted in India and globally due to the urgent medical needs arising from a pandemic that was of mammoth proportion.
Decentralized trials which became a necessity during the multiple 2020 lockdowns are not only a way to ensure your trial can continue even in a situation of global crisis but also a way to diversify study participants who have taken up clinical courses and attend to the needs of patients in trials.
The decentralized approach will be considered more and more in the planning of new studies, courses and careers as well.